Judith Metzdorf

St. Josef Hospital
Bochum, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

PTCy or ATG for Matched Transplantation in Myelofibrosis.

PTCy or ATG for Matched Transplantation in Myelofibrosis.

Journal: American journal of hematology

Published: January 03, 2026

Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group.

Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group.

Journal: Transplantation and cellular therapy

Published: September 10, 2025

Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in Remission.

Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in Remission.

Journal: Transplantation and cellular therapy

Published: August 20, 2025

Predictive Capacity of Peri-Transplant Measurable Residual Disease Thresholds in NPM1-Mutant Acute Myeloid Leukemia.

Predictive Capacity of Peri-Transplant Measurable Residual Disease Thresholds in NPM1-Mutant Acute Myeloid Leukemia.

Journal: Blood advances

Published: July 29, 2025

Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.

Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.

Journal: Blood advances

Published: July 29, 2025

Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.

Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.

Journal: Blood advances

Published: July 29, 2025

Outcome after Treosulfan-based conditioning in a real-world MDS cohort.

Outcome after Treosulfan-based conditioning in a real-world MDS cohort.

Journal: Bone marrow transplantation

Published: June 23, 2025

A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson's Disease Modelling.

A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson's Disease Modelling.

Journal: Cells

Published: April 01, 2021

Short-chain fatty acids in the context of Parkinson's disease.

Short-chain fatty acids in the context of Parkinson's disease.

Journal: Neural regeneration research

Published: March 01, 2021

Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease.

Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease.

Journal: Molecules (Basel, Switzerland)

Published: May 04, 2020

Fingolimod for Irradiation-Induced Neurodegeneration.

Fingolimod for Irradiation-Induced Neurodegeneration.

Journal: Frontiers in neuroscience

Published: February 13, 2019

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.

Journal: Cells

Published: December 31, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026